Form 4: USANA CIO Peter Benedict Reports Stock Transactions

USANA Health Sciences Chief Information Officer Peter Benedict reported the acquisition of 3,906 common shares and the disposition of 1,174 shares for tax purposes.

Summary

• Peter Benedict, USANA Health Sciences' Chief Information Officer, reported transactions on February 27, 2026.
• Acquired 3,906 shares of common stock through the vesting of restricted stock units.
• Disposed of 1,174 shares of common stock at a price of $21.52 per share.
• The disposition was likely to cover tax obligations related to the vesting of restricted stock units.
• Following these transactions, Benedict directly owns 4,553 shares of common stock and 38,602 restricted stock units.
• Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
• Restricted Stock Units vest 25% on the anniversary of February 27, 2025, indicating the reported acquisition is part of a scheduled vesting event.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine insider transaction related to executive compensation. The net increase in direct ownership (3,906 acquired vs. 1,174 disposed) is slightly positive, indicating continued executive alignment with shareholder interests.

Positives

• The acquisition of 3,906 shares of common stock indicates an increase in direct ownership by a key executive, aligning their interests with shareholders.
• The vesting of restricted stock units demonstrates the company's compensation structure and executive retention mechanisms are functioning as intended.

Negatives

• The disposition of 1,174 shares, while common for tax purposes, reduces the executive's direct shareholding.

Future Outlook

No specific forward-looking statements or guidance are provided in this Form 4 filing, which is a report of past insider transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures of insider transactions, providing transparency into executive stock ownership changes. These transactions, particularly those related to RSU vesting and tax-related sales, are common across industries as part of executive compensation plans.

Comparison to Industry Standards

• Form 4 filings are standard regulatory disclosures for insider transactions across all publicly traded companies in the U.S.
• The reported transactions, involving RSU vesting and subsequent tax-related sales, are typical for executive compensation structures in companies like Herbalife Nutrition Ltd. (HLF) or Nu Skin Enterprises, Inc. (NUS), which also operate in the direct selling and health/wellness sectors.
• The disposition price of $21.52 is specific to USNA's stock performance on the transaction date and reflects market conditions at that time.

Related Party Transactions

• The reported transactions involve Peter Benedict, a Chief Information Officer of USANA Health Sciences, making them related-party transactions as per SEC regulations for insider reporting.

Stakeholder Impact

• Shareholders: Increased transparency regarding executive stock ownership and compensation. The net increase in shares held by the CIO could be seen as a positive signal of management's belief in the company.
• Employees: Reflects the company's executive compensation practices, which may influence broader employee incentive programs.

Key Dates

Recommendation

This Form 4 filing details a routine insider transaction involving the vesting of restricted stock units and a subsequent sale to cover tax obligations. Such transactions are common and do not typically signal a change in the company's fundamental outlook or warrant a strong buy or sell recommendation. The net increase in shares held by the CIO is a neutral to slightly positive indicator, suggesting continued alignment without providing new material information to alter an existing investment thesis.

Keywords

USANA Health Sciences, USNA, Peter Benedict, Insider Trading, Form 4, Stock Transaction, Restricted Stock Units, Executive Compensation, CIO